Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-27.82%Return on Assets
VS
Market
Sector
Industry
History
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information
Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTAYSHA GENE THERAPIES INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TSHA - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 333.33M | $ -92.72M | -27.82% |
| 3/31/2025 | $ 138.36M | $ -86.77M | -62.71% |
| 12/31/2024 | $ 160.36M | $ -89.3M | -55.68% |
| 9/30/2024 | $ 180.22M | $ -22.77M | -12.64% |
| 6/30/2024 | $ 200.39M | $ -114.33M | -57.06% |
| 3/31/2024 | $ 153M | $ -118M | -77.13% |
| 12/31/2023 | $ 172.73M | $ -111.57M | -64.59% |
| 9/30/2023 | $ 195.77M | $ -215.03M | -109.84% |
| 6/30/2023 | $ 81.54M | $ -124.25M | -152.37% |
| 3/31/2023 | $ 101.6M | $ -133.53M | -131.42% |
Key Performance Insights, Last 5 Years
- TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) ROA stands at 0%.
- Over the past 5 years, TAYSHA GENE THERAPIES INC's average ROA has been -82.28%.
- The median ROA for TAYSHA GENE THERAPIES INC during this period was -70.86%
- TAYSHA GENE THERAPIES INC reached its highest ROA over the past 5 years at -12.64%.
- The lowest ROA recorded by TAYSHA GENE THERAPIES INC in the same timeframe -152.37%
TAYSHA GENE THERAPIES INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for TAYSHA GENE THERAPIES INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Assets [ $ 279.27M ]
(=) ROA [ 0% ] TSHA - Return on Assets, Last 5 years
-152.37%
Minimum
Jun 30, 2023
-12.64%
Maximum
Sep 30, 2024
-82.28%
Average
-70.86%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.45K |
|---|---|
| min | -33.42% |
| max | 33.98% |
| average | 0.1% |
| median | 1.53% |
| std | 10.63% |